Literature DB >> 18332468

Optimizing endocrine therapy for estrogen receptor-positive breast cancer: treating the right patients for the right length of time.

Nancy U Lin, Eric P Winer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18332468     DOI： 10.1200/JCO.2007.14.7744

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  HSP90 empowers evolution of resistance to hormonal therapy in human breast cancer models.

Authors:  Luke Whitesell; Sandro Santagata; Marc L Mendillo; Nancy U Lin; David A Proia; Susan Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

2.  Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments.

Authors:  Ada Ao; Brian J Morrison; Heiman Wang; J Alejandro López; Brent A Reynolds; Jianrong Lu
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240

3.  Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma.

Authors:  Vijay Pandey; Zheng-Sheng Wu; Min Zhang; Rui Li; Jian Zhang; Tao Zhu; Peter E Lobie
Journal:  Breast Cancer Res       Date:  2014-09-30       Impact factor: 6.466
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.